Integrated Report

Integrated Report 2022 (For the year ended March 31, 2022)


By Section


Value Creation Strategies

Practice & Performance

  • Strategy 1 Enhance innovation base with new approaches to drug discovery
  • Strategy 2 Deliver the highest performance of clinical development Message from the Executive Officers
  • Strategy 3 Pipeline expansion through strategic investment
  • Strategy 4 Regional strategy centering in Japan, North America and China
  • Strategy 5 Launch frontier business
  • Flexible and efficient organization and operations
  • Corporate culture and talent to drive innovation
  • Message from the Executive Officer in Charge of Human Resources
  • Digital transformation


Financial & Corporate Information